Stacy Ku
Stock Analyst at TD Cowen
(2.55)
# 2,216
Out of 5,182 analysts
7
Total ratings
71.43%
Success rate
11.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stacy Ku
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNXP Tonix Pharmaceuticals Holding | Initiates: Buy | $22 | $14.09 | +56.14% | 1 | May 4, 2026 | |
| GRCE Grace Therapeutics | Maintains: Buy | $12 → $8 | $2.34 | +241.88% | 1 | Apr 24, 2026 | |
| SUPN Supernus Pharmaceuticals | Maintains: Buy | $45 → $60 | $51.53 | +16.44% | 1 | Oct 23, 2025 | |
| BCRX BioCryst Pharmaceuticals | Reinstates: Buy | $30 | $8.62 | +248.03% | 1 | Oct 15, 2025 | |
| CNTA Centessa Pharmaceuticals | Initiates: Buy | n/a | $39.60 | - | 1 | Jan 7, 2025 | |
| KALV KalVista Pharmaceuticals | Initiates: Buy | $30 | $26.73 | +12.23% | 1 | Jan 7, 2025 | |
| VRCA Verrica Pharmaceuticals | Maintains: Buy | $150 → $100 | $7.99 | +1,151.56% | 1 | Oct 21, 2024 |
Tonix Pharmaceuticals Holding
May 4, 2026
Initiates: Buy
Price Target: $22
Current: $14.09
Upside: +56.14%
Grace Therapeutics
Apr 24, 2026
Maintains: Buy
Price Target: $12 → $8
Current: $2.34
Upside: +241.88%
Supernus Pharmaceuticals
Oct 23, 2025
Maintains: Buy
Price Target: $45 → $60
Current: $51.53
Upside: +16.44%
BioCryst Pharmaceuticals
Oct 15, 2025
Reinstates: Buy
Price Target: $30
Current: $8.62
Upside: +248.03%
Centessa Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: n/a
Current: $39.60
Upside: -
KalVista Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: $30
Current: $26.73
Upside: +12.23%
Verrica Pharmaceuticals
Oct 21, 2024
Maintains: Buy
Price Target: $150 → $100
Current: $7.99
Upside: +1,151.56%